Tech Company Financing Transactions
EndoQuest Robotics Funding Round
On 12/4/2023, EndoQuest Robotics received $42 million in Series C financing from CE Ventures, McNair Interests and Puma Venture Capital.
Transaction Overview
Company Name
Announced On
12/4/2023
Transaction Type
Venture Equity
Amount
$42,000,000
Round
Series C
Investors
Proceeds Purpose
The newly acquired capital will be instrumental in driving key initiatives, including further research and development, regulatory milestones, commercialization efforts, and strengthening the Company's position as the frontrunner in flexible endoluminal robotics.
Company Information
Company Status
Private & Independent
Industry
Robotics
Mailing Address
9310 Kirby Dr 100
Houston, TX 77054
USA
Houston, TX 77054
USA
Phone
Website
Email Address
Overview
Endoluminal and single-incision surgery are the next frontiers of minimally invasive surgery performed through a transumbilical incision or via the body's natural orifices, including transoral and transanal. This revolutionary approach minimizes external incisions and associated complications, in contrast to conventional open, laparoscopic or robotic surgery, which require incisions through healthy tissue to access the site of surgical intervention.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kurt Azarbarzin
Chief Financial Officer
Christine Antalik
Chief Medical Officer
Todd Wilson
Browse more venture capital transactions:
Prev: 12/4/2023: AM Batteries venture capital transaction
Next: 12/4/2023: Gravel venture capital transaction
Share this article
About Our VC Transactions Data
We report on funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs